[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence
R Nevola, R Ruocco, L Criscuolo, A Villani… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …
are constantly increasing. Despite the availability of potentially curative treatments (liver …
[HTML][HTML] Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …
METTL3-m6A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma
L Wang, Q Yang, Q Zhou, F Fang, K Lei, Z Liu, G Zheng… - Cancer Letters, 2023 - Elsevier
Lenvatinib is emerging as the first-line therapeutic option for advanced hepatocellular
carcinoma (HCC), but drug resistance remains a major hurdle for its long-term therapy …
carcinoma (HCC), but drug resistance remains a major hurdle for its long-term therapy …
[HTML][HTML] Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target
tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune …
tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune …
[HTML][HTML] Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance
C Huang, P Azizi, M Vazirzadeh… - Journal of Translational …, 2023 - Springer
Cancer is a complex disease with many contributing factors, and researchers have gained
extensive knowledge that has helped them understand the diverse and varied nature of …
extensive knowledge that has helped them understand the diverse and varied nature of …
[HTML][HTML] FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis
W Hu, C Zhou, Q Jing, Y Li, J Yang, C Yang… - Cancer Cell …, 2021 - Springer
Background Ferroptosis is a newly identified type of programmed cell death, which
preferentially targets iron-rich cancer cells such as hepatocellular carcinoma (HCC). Ferritin …
preferentially targets iron-rich cancer cells such as hepatocellular carcinoma (HCC). Ferritin …
COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images
Abstract COVID-19 (SARS-CoV-2), which causes acute respiratory syndrome, is a
contagious and deadly disease that has devastating effects on society and human life …
contagious and deadly disease that has devastating effects on society and human life …
[HTML][HTML] Phenolic metabolites as therapeutic in inflammation and neoplasms: Molecular pathways explaining their efficacy
W Liu, X Cui, Y Zhong, R Ma, B Liu, Y Xia - Pharmacological Research, 2023 - Elsevier
Polyphenols, also known as phenolic compounds, are chemical substances containing
aromatic rings as well as at least two hydroxyl groups. Natural phenolic compounds exist …
aromatic rings as well as at least two hydroxyl groups. Natural phenolic compounds exist …
Hepatocellular carcinoma: a narrative review on current knowledge and future prospects
B Alawyia, C Constantinou - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement Hepatocellular carcinoma is the fourth leading cause of cancer-related
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
deaths worldwide and its associated mortality rate is expected to rise within the next decade …
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells
L Gu, Y Zhu, M Lee, A Nguyen… - Proceedings of the …, 2023 - National Acad Sciences
Although viral hepatocellular carcinoma (HCC) is declining, nonviral HCC, which often is the
end stage of nonalcoholic or alcoholic steatohepatitis (NASH, ASH), is on an upward …
end stage of nonalcoholic or alcoholic steatohepatitis (NASH, ASH), is on an upward …